AC8 0.00% 4.0¢ auscann group holdings ltd

Ann: AusCann Releases Low-dose Form Capsule, page-8

  1. 124 Posts.
    lightbulb Created with Sketch. 7
    I'm assuming that this is just a release regarding the new milestone and don't see it as changing the approach and plan to continue with clinical trials...

    perhaps, as with many of the existing products in the market, they are eother referring to sales after clinical trials or small volumes via the SAS?

    HC broken: Hold / Held
    Last edited by patrick10101: 18/02/20
 
watchlist Created with Sketch. Add AC8 (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.